Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.83% |
| NATUS MEDICA | BABY | 5.90% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 5.18% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Estimates have been rising for retailer Williams-Sonoma, Inc. ( WSM - Snapshot Report ) after the company delivered better than expected results for the third quarter of 2011. Same-store sales rose 7% in the quarter, driven by a whopping 27% surge in its West Elm division.
It is a Zacks #2 Rank (Buy) stock.
The company also has a solid balance sheet and generates strong free cash flow, which has allowed it to buyback stock and raise its dividend. It currently yields 1.7%.
Valuation is reasonable too, with shares sporting a PEG ratio of 1.0.
Higher-End Still Strong
Despite low consumer confidence and a squeezing of the middle class, higher-end retail has been exceptionally strong over the last several months, and Williams-Sonoma has been no exception.
Along with the Willams-Sonoma brand, the company operates Pottery Barn and West Elm. It is headquartered in San Francisco, California and has 589 stores throughout North America.
Third Quarter Results
The company reported better than expected results for the third quarter of 2011 on November 17. Earnings per share came in at $0.41, beating the Zacks Consensus Estimate by 3 cents. It was a 17% increase over the same quarter in 2010.
Net revenues rose 6% to $867 million, ahead of the Zacks Consensus Estimate of $856 million. This was driven by a stellar 7.3% increase in same-store sales for the quarter. The company's West Elm brand led the way with a remarkable 27.0% increase in same-store sales while the Pottery Barn division saw a 7.0% increase.
Gross profit expanded 10 basis points to 38.3% of net revenues as the company leveraged its fixed occupancy expenses. Meanwhile, selling, general and administrative expenses declined from 30.9% to 30.4% of net revenues.
These factors led to a 60 basis point improvement in the operating margin to 7.9%.
Outlook
CEO Laura Alber stated in the third quarter release that the company is encouraged by the positive consumer response to its seasonal and holiday merchandise assortments as it enters the all-important fourth quarter. Analysts revised their earnings estimates higher for both 2011 and 2012 off the strong quarter, sending the stock to a Zacks #2 Rank (Buy).
The Zacks Consensus Estimate for 2011 increased to $2.26, at the upper end of management's guidance. This represents 16% EPS growth over 2010. The 2012 consensus estimate rose to $2.53, corresponding with 12% EPS growth.
As you can see in the company's Price & Consensus chart, consensus estimates have been steadily rising over the last several months as the company continues to outperform expectations:
Returning Value to Shareholders
William-Sonoma has a strong balance sheet and generates solid free cash flow, which has allowed it to return value to shareholders through stock buybacks and dividends.
In the third quarter, the company spent approximately $31 million repurchasing 963,700 shares of its common stock. It also pays a dividend that yields 1.7%.
Since it began paying a dividend in 2006, Williams-Sonoma has increased it 5 times at a compound annual growth rate of 11%.
Reasonable Valuation
The valuation picture looks reasonable for WSM. Shares trade at 15.8x 12-month forward earnings, in-line with the industry average, and a discount to its 10-year median of 19.3x.
Its PEG ratio is 1.0 based on a 5-year EPS growth rate of 15.3%.
The Bottom Line
With strong growth prospects, rising earnings estimates, shareholder-friendly management and reasonable valuation, Williams-Sonoma offers plenty to like.
Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research and Co-Editor of the Reitmeister Value Investor.
Read the full reports :
Snapshot Report on WSM